Edition:
United Kingdom

Compugen Ltd (CGEN.OQ)

CGEN.OQ on NASDAQ Stock Exchange Global Market

2.50USD
13 Dec 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.50
Open
$2.50
Day's High
$2.55
Day's Low
$2.35
Volume
37,025
Avg. Vol
20,553
52-wk High
$6.20
52-wk Low
$2.25

Latest Key Developments (Source: Significant Developments)

COMPUGEN REPORTS Q3 LOSS PER SHARE $0.19
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Compugen Ltd ::COMPUGEN REPORTS THIRD QUARTER 2017 RESULTS.Q3 LOSS PER SHARE $0.19.‍AS OF SEPTEMBER 30, 2017, CASH AND CASH RELATED ACCOUNTS TOTALED $38.5 MILLION, COMPARED WITH $61.5 MILLION AS OF DECEMBER 31, 2016​.  Full Article

Compugen to initiate manufacturing of COM902
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Compugen Ltd :Compugen Ltd - ‍advancing COM902 into manufacturing in anticipation of filing an investigational new drug (IND) application in 2019​.Compugen Ltd - ‍entered into process development and manufacturing service agreement with Bayer Healthcare LLC (Bayer) to produce COM902.Compugen Ltd - ‍working towards filing IND for COM902 in 2019​.  Full Article

Compugen files for mixed shelf of up to $200 million
Tuesday, 9 Aug 2016 

Compugen Ltd :Files for mixed shelf of upto $200 million - SEC filing.  Full Article

Compugen says discloses lead therapeutic candidate for CGEN-15029 immuno-oncology program
Wednesday, 22 Jun 2016 

Compugen : Discloses Lead Therapeutic Candidate For Cgen-15029 immuno-oncology program .Ind filing for com701 anticipated next year.  Full Article

Compugen reports Q1 loss of $0.17 per share
Tuesday, 10 May 2016 

Compugen Ltd : Compugen ltd. Reports first quarter 2016 financial results . Q1 loss per share $0.17 .Q1 revenue $100,000.  Full Article

BRIEF-COMPUGEN REPORTS Q3 LOSS PER SHARE $0.19

* ‍AS OF SEPTEMBER 30, 2017, CASH AND CASH RELATED ACCOUNTS TOTALED $38.5 MILLION, COMPARED WITH $61.5 MILLION AS OF DECEMBER 31, 2016​ Source text for Eikon: Further company coverage: